Schedule 13D ownership disclosure
Vor BioPharma Inc
Common Stock, $0.0001 par value per share · CUSIP: 929033207
Event date: 2025-12-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ForGrowth III PA B.V.Reported CIK 0002050902
Shares: 10,237,714 · Class: 9.99%
- Forbion Growth Opportunities Fund III Cooperatief U.A.
Shares: 10,237,714 · Class: 9.99%
- Forbion Growth III Management B.V.
Shares: 10,237,714 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-330843
- Form type
- SCHEDULE 13D
- Filer
- ForGrowth III PA B.V.
- CIK
- CIK 2050902
- Filed
- Dec 23, 2025
- Reporting period
- Dec 18, 2025
- Description
- Schedule 13D beneficial ownership